All Pharma articles – Page 29
-
NewsSerious drug shortages at four in five trusts
Patients struggle to obtain drugs for life-threatening conditions in 80 per cent of NHS trusts in England and Wales, a survey suggests.
-
NewsMeasures to tackle patient age discrimination imposed
Age discrimination against NHS patients is to be made illegal, ministers have confirmed.
-
HSJ Local
Gloucestershire considers unlicenced use of Avastin
FINANCE: The Gloucestershire Clinical Commissioning Group has agreed to support Gloucestershire Hospitals Foundation Trust decision to allow clinicans to prescribe an unlicensed medicine.
-
NewsGovernment wrong to focus on 'breakthrough' drug research, warns pharma chief
Fears have been expressed for the future of medical drug research in the UK by the head of the association representing Britain’s pharmaceutical industry.
-
NewsMinister rejects cancer drugs fund
The Welsh health minister Lesley Griffiths has told a group of top medics she is standing firm on the issue of a cancer drugs fund for Wales, saying the scheme would not work.
-
NewsProviders urged to collaborate to speed clinical trial approvals
Providers need to work together to speed up the approval process for clinical trials if the NHS is to realise its potential as a research resource, a senior pharmaceutical industry figure has said
-
NewsLansley confirms NICE will no longer take funding decisions
The National Institute for Health and Clinical Excellence will no longer directly decide whether the NHS funds a drug under the proposed new pricing system, health secretary Andrew Lansley has confirmed.
-
CommentMedia Watch: RCN congress sparks raft of health warnings
Health policy in the news this week.
-
Comment'A culture shift can help reduce prescription wastage'
Patient involvement is paramount to prescription policy.
-
NewsDrug costs 'have to be secret' under new pricing system
Drug prices agreed under the government’s proposed new pricing system would have to remain secret if drug companies are to buy into it, a senior figure in the pharmaceutical industry has warned.
-
News
Mike Rawlins: NICE drug judgements can be improved
Judgements on which drugs should be paid for by the NHS can be improved, the chair of the National Institute for Health and Clinical Excellence has said.
-
NewsMPs warn over medicine shortages
Patients are suffering because of a shortage of some NHS prescription medicines, a parliamentary group has warned.
-
NewsIncreased sleeping pill use costs NHS £50m
The NHS spent nearly £50m on sleeping pills last year, a sharp rise on previous costs, new figures reveal.
-
CommentMichael White: driving down the cost of drug deals
The NHS should have little sympathy for Big Pharma.
-
NewsValue-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.
-
News
NICE guidance on cost-saving drug not sought by DH
The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.
-
NewsOne in 20 GP prescriptions contains an error
Around one in 20 prescriptions written by family doctors contains an error, according to a newly published study.
-
NewsPCTs bypassed in applications to Cancer Drugs Fund
Doctors have been told they can bypass primary care trust funding processes and apply direct to the controversial Cancer Drugs Fund in certain cases, under new guidelines issued by the Department of Health.
-
NewsNovartis launches legal challenge against PCT cluster
A pharmaceutical company is taking a primary care trust cluster to court over its decision to encourage the use of a cheaper, unlicensed drug in a case that could be worth millions to the NHS.
-
Comment'The NHS could miss the next care revolution'
HSJ interviews GE Healthcare president John Dineen.